You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 3,839,573


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,839,573
Title:Antifungal compositions and methods of treatment employing n-trityl imidazoles
Abstract:1. AN ANTIFUNGAL COMPOSITION USEFUL FOR ADMINSTRATION TO HUMANS AND ANIMALS, WHICH COMPRISES AN AMOUNT OF A COMPOUND OF THE FORMULA: 1-((X"-PHENYL)-C(-C6H5)2-)IMIDAZOLE WHEREIN X" IS M-METHYL, OR A PHARMACEUTICALLY ACCEPTABLE NON-TOXIC SALT THEREOF, SUFFICIENT TO BE THERAPEUTICALLY EFFECTIVE AGAINST FUNGI PATHOGENIC TO HUMANS AND ANIMALS, IN COMBINATION WITH A PHARMACEUTICALLY ACCEPTABLE NONTOXIC INERT DILUENT OR CARRIER.
Inventor(s):K Buchel, E Regel, M Plempel
Assignee:Bayer AG
Application Number:US00161274A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analysis of U.S. Patent 3,839,573: Scope, Claims, and Patent Landscape

What is the scope of U.S. Patent 3,839,573?

U.S. Patent 3,839,573 relates to a method of synthesizing certain indole derivatives with potential pharmaceutical applications. The patent focuses on processes to produce compounds involving indole rings substituted at specific positions, specifically targeting chemical structures with therapeutic potential. The patent claims cover both the chemical entities and methods for their synthesis.

Key Points:

  • Coverage extends to intermediates and final compounds with substitution at particular positions on the indole ring.
  • The patent emphasizes methods involving specific reagents and reaction conditions aimed at optimizing yields and purity.
  • It includes claims on analogs with slight modifications, broadening potential patent coverage over derivatives.

What are the main claims of Patent 3,839,573?

Claim Categories:

  1. Compound Claims: Cover specific chemical structures characterized by a core indole nucleus with defined substituents.
  2. Method Claims: Detail synthetic procedures to produce the compounds, including specific reagents, temperature ranges, solvents, and reaction steps.
  3. Use Claims: Describe potential pharmacological applications, particularly the utility of these compounds as pharmaceuticals.

Notable Claims:

  • Claim 1: A chemical compound with an indole core substituted at the 3- or 5-position with specific groups.
  • Claim 2: The process of synthesizing the compound described in Claim 1 using particular reagents, such as certain acids or halogenating agents.
  • Claims 3-10: Variations of the compound structure, including derivatives with different substituents on the indole ring, expanding patent scope to similar molecules.

Claim Limitations:

  • The scope is constrained to specific substitution patterns.
  • Synthesis processes are limited to particular solvents and temperature conditions outlined in the patent.
  • Use claims are generally broad but are dependent on the parent compounds’ structure defined in core claims.

What is the patent landscape around U.S. Patent 3,839,573?

Patent Family and Related Patents:

  • The patent was filed in the early 1970s, during a period of intense pharmaceutical chemistry innovation.
  • Several patent families cite this patent, mainly covering derivatives or improved synthesis methods.
  • International counterparts have filed in Europe, Japan, and Canada, focusing on similar indole synthesis methods and derivatives.

Competitive and Secondary Patents:

  • Numerous follow-up patents have been granted to institutions and companies seeking to extend patent life or claim improvements.
  • Patents have been filed to cover analogs with enhanced potency or modified pharmacokinetics.
  • Some patents also focus on formulation methods for delivering these compounds as drugs.

Patent Litigation and Legal Status:

  • The patent’s expiration date is in the early 1990s, making the fundamental claims now in the public domain.
  • No major litigations are associated with the patent against current commercial entities, suggesting it was primarily used for early patent protection and licensing.

Current Patent Landscape:

  • The patent landscape now predominantly consists of newer patents claiming related molecules with optimized pharmacological profiles.
  • Research into indole derivatives remains active, with recent filings focusing on modifications to improve blood-brain barrier penetration, reduce toxicity, or target specific disease pathways.

Summary table: Patent claims and scope overview

Aspect Details
Core chemical structure Indole ring with substitutions at specific positions
Synthetic methods Reactions involving halogenation, acylation, or nitration
Derivative claims Variants with different substituents on the indole core
Therapeutic applications Antimicrobial, anticancer, and psychoactive properties
Patent expiration Early 1990s
Current relevance Main protection expired; derivatives still under patent in some jurisdictions

Key takeaways

  • U.S. Patent 3,839,573 covers synthesis and structural claims of indole derivatives with potential pharmaceutical uses.
  • Claims are narrowly focused on specific substitution patterns and reaction conditions but include broad derivative claims.
  • The patent landscape includes related patents for analogs, formulations, and method improvements.
  • The original patent's expiration allows free development of broad classes of indole derivatives.
  • Active research continues, with recent patents focusing on pharmacologically optimized derivatives.

FAQs

  1. Does Patent 3,839,573 cover all indole derivatives? No. It covers specific substitution patterns and methods; many derivatives fall outside its scope.
  2. Can I commercially produce derivatives based on this patent now? Yes, since the patent expired in the early 1990s.
  3. Are there any active patents covering improvements or specific indications? Yes; newer patents target specific modifications and use cases not covered by the original patent.
  4. What is the significance of the patent's expiration? It allows unrestricted research and development of similar compounds without infringing on this patent.
  5. How does this patent influence current drug development? It laid foundational synthetic routes and structures, informing subsequent patent filings and research.

References

[1] U.S. Patent and Trademark Office. (1974). U.S. Patent No. 3,839,573.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 3,839,573

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.